QQQ   413.25 (-2.40%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   413.25 (-2.40%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   413.25 (-2.40%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   413.25 (-2.40%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$6.88
-0.1%
$9.54
$2.09
$14.84
$487.72M0.055.49 million shs2.70 million shs
(ITC) stock logo
ITC
(ITC)
$45.50
$0.00
$30.33
$47.46
N/AN/A1.80 million shsN/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
-2.13%-17.98%-21.17%-25.51%+15.41%
(ITC) stock logo
ITC
(ITC)
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.1183 of 5 stars
3.32.00.00.01.71.70.0
(ITC) stock logo
ITC
(ITC)
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.00118.02% Upside
(ITC) stock logo
ITC
(ITC)
N/AN/AN/AN/A

Current Analyst Ratings

Latest ALT, ITC, DTS, and EOL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
1/24/2024
Altimmune, Inc. stock logo
ALT
Altimmune
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$13.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,134.24N/AN/A$2.75 per share2.50
(ITC) stock logo
ITC
(ITC)
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
(ITC) stock logo
ITC
(ITC)
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
(ITC) stock logo
ITC
(ITC)
$0.861.89%N/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
(ITC) stock logo
ITC
(ITC)
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
(ITC) stock logo
ITC
(ITC)
84.21%

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
(ITC) stock logo
ITC
(ITC)
3.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
(ITC) stock logo
ITC
(ITC)
N/AN/AN/ANot Optionable

ALT, ITC, DTS, and EOL Headlines

SourceHeadline
ITC Infotech buys Pune-based cloud service provider for Rs 485 croreITC Infotech buys Pune-based cloud service provider for Rs 485 crore
telegraphindia.com - April 19 at 2:49 PM
ITC arm inks pact to acquire 100% stake in Blazeclan TechnologiesITC arm inks pact to acquire 100% stake in Blazeclan Technologies
business-standard.com - April 19 at 2:49 PM
ITC Stocks Live Updates: ITC Maintains Stability with Previous Day Close at Rs 418.85 and Steady Trading VolumeITC Stocks Live Updates: ITC Maintains Stability with Previous Day Close at Rs 418.85 and Steady Trading Volume
economictimes.indiatimes.com - April 19 at 2:49 PM
ITC shares rise on ITC Infotech deal to buy Pune-based IT firm for Rs 485 croreITC shares rise on ITC Infotech deal to buy Pune-based IT firm for Rs 485 crore
msn.com - April 19 at 2:49 PM
ITC shares gain after subsidiary signs deal to buy Pune-based IT firmITC shares gain after subsidiary signs deal to buy Pune-based IT firm
fortuneindia.com - April 19 at 2:49 PM
ITC shares rise as subsidiary to acquire cloud services firmITC shares rise as subsidiary to acquire cloud services firm
msn.com - April 19 at 2:49 PM
Itc share price Today Live Updates : Itc Stock Rises in Positive Trading TrendItc share price Today Live Updates : Itc Stock Rises in Positive Trading Trend
livemint.com - April 19 at 2:49 PM
Why ITC Shares Are Climbing Over 1% Today Amid Market GloomWhy ITC Shares Are Climbing Over 1% Today Amid Market Gloom
msn.com - April 19 at 9:48 AM
Groups ask ITC to kill possible herbicide dutiesGroups ask ITC to kill possible herbicide duties
kfgo.com - April 19 at 9:48 AM
ITC Infotech to acquire Blazeclan to augment its multi-cloud capabilitiesITC Infotech to acquire Blazeclan to augment its multi-cloud capabilities
ibsintelligence.com - April 18 at 7:18 PM
ITC Infotech to buy cloud consulting firm BlazeclanITC Infotech to buy cloud consulting firm Blazeclan
timesofindia.indiatimes.com - April 18 at 7:18 PM
National commodity groups call on ITC to nix herbicide duty petitionNational commodity groups call on ITC to nix herbicide duty petition
hpj.com - April 18 at 7:18 PM
ITC Infotech to acquire cloud services firm Blazeclan for up to ₹485 croreITC Infotech to acquire cloud services firm Blazeclan for up to ₹485 crore
thehindu.com - April 18 at 2:18 PM
ITC Update: Takeaways from Certain Replacement Automotive LampsITC Update: Takeaways from Certain Replacement Automotive Lamps
jdsupra.com - April 18 at 2:18 PM
ITC Infotech to acquire Blazeclan Technologies for up to Rs 485 croreITC Infotech to acquire Blazeclan Technologies for up to Rs 485 crore
msn.com - April 18 at 2:18 PM
ITCs subsidiary to acquire Blazeclan Technologies for Rs 485 croreITC's subsidiary to acquire Blazeclan Technologies for Rs 485 crore
msn.com - April 18 at 2:18 PM
Russias Olya port handles agro-product cargo via North-South ITC for first timeRussia's Olya port handles agro-product cargo via North-South ITC for first time
en.trend.az - April 18 at 8:09 AM
Itc share price Today Live Updates : Itc Stock Price Drops as Company Trades in the RedItc share price Today Live Updates : Itc Stock Price Drops as Company Trades in the Red
livemint.com - April 18 at 8:09 AM
ITC subsidiary to acquire Blazeclan Tech for Rs 4.85 croreITC subsidiary to acquire Blazeclan Tech for Rs 4.85 crore
msn.com - April 18 at 8:09 AM
Itc share price Today Live Updates : ITC stock plummets as trading takes a negative turnItc share price Today Live Updates : ITC stock plummets as trading takes a negative turn
livemint.com - April 18 at 8:09 AM
ITC Infotech to acquire Blazeclan TechnologiesITC Infotech to acquire Blazeclan Technologies
business-standard.com - April 18 at 8:09 AM
ITC arm to buy 100% stake in Blazeclan Technologies for ₹485 croreITC arm to buy 100% stake in Blazeclan Technologies for ₹485 crore
cnbctv18.com - April 18 at 8:09 AM
Bajaj Auto, Infosys, ITC: Stocks to watch on FridayBajaj Auto, Infosys, ITC: Stocks to watch on Friday
zeebiz.com - April 18 at 8:09 AM
Itc share price Today Live Updates : ITC Stock Plunges in Todays TradingItc share price Today Live Updates : ITC Stock Plunges in Today's Trading
livemint.com - April 18 at 1:35 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
(ITC) logo

(ITC)

NYSE:ITC
ITC Holdings Corp. (ITC Holdings) is a holding company. The Company is engaged in owning, operating, maintaining and investing in transmission infrastructure. The Company's business consists primarily of the electric transmission operations of its Regulated Operating Subsidiaries. Its Regulated Operating Subsidiaries include International Transmission Company (ITCTransmission), Michigan Electric Transmission Company, LLC (METC), ITC Midwest LLC (ITC Midwest). The operations performed by its Regulated Operating Subsidiaries fall into the various categories, such as asset planning; engineering, design and construction; maintenance, and real time operations. Its customers include investor-owned utilities, municipalities, cooperatives, power marketers and alternative energy suppliers. It owns and operates high-voltage systems in Michigan's Lower Peninsula and portions of Iowa, Minnesota, Illinois, Missouri, Kansas and Oklahoma.